Cargando…

Morbidity and Mortality After Major Hepatic Resection in Cirrhotic Patients With Hepatocellular Carcinoma

Major hepatic resection was carried out on 23 adult patients with hepatocellular carcinoma (HCC) and underlying cirrhosis of the liver (macronodular in six cases, micronodular in 11, and mixed type cirrhosis in six). Pre-operative liver functional state was Child's class A in 19, class B in thr...

Descripción completa

Detalles Bibliográficos
Autores principales: Nagasue, Naofumi, Yukaya, Hirofumi, Kohno, Hitoshi, Chang, Yu-Chung, Nakamura, Teruhisa
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 1988
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2423506/
https://www.ncbi.nlm.nih.gov/pubmed/2856432
http://dx.doi.org/10.1155/1988/93437
_version_ 1782156114217926656
author Nagasue, Naofumi
Yukaya, Hirofumi
Kohno, Hitoshi
Chang, Yu-Chung
Nakamura, Teruhisa
author_facet Nagasue, Naofumi
Yukaya, Hirofumi
Kohno, Hitoshi
Chang, Yu-Chung
Nakamura, Teruhisa
author_sort Nagasue, Naofumi
collection PubMed
description Major hepatic resection was carried out on 23 adult patients with hepatocellular carcinoma (HCC) and underlying cirrhosis of the liver (macronodular in six cases, micronodular in 11, and mixed type cirrhosis in six). Pre-operative liver functional state was Child's class A in 19, class B in three, and class C in one. The operations performed were extended right lobectomy in four patients, right lobectomy in 10, left lobectomy in one, and left lateral segmentectomy in eight. Fifteen postoperative complications were found in 10 patients, five of whom had duplicated complications and finally died of liver failure 15–65 days after operation. In three of those five patients, other complications (hemorrhagic shock in two and portal thrombosis in one) had preceded liver failure. Eighteen patients tolerated the resection and were discharged from hospital. However, among 13 noncirrhotic patients with HCC who had undergone major hepatic resection during the same period of time, only two had postoperative complications and all patients were discharged from hospital. The 1-, 2- and 3-year survival rates in the 23 cirrhotics were 60.9%, 37.5% and 24.9% respectively, whereas the 1–5-year survival rates were all 61.5% in the 13 noncirrhotics. Thus, major hepatic resection may be indicated in selected patients with HCC and associated cirrhosis, but meticulous managements during and after operation are mandatory to prevent fatal postoperative liver failure.
format Text
id pubmed-2423506
institution National Center for Biotechnology Information
language English
publishDate 1988
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-24235062008-07-08 Morbidity and Mortality After Major Hepatic Resection in Cirrhotic Patients With Hepatocellular Carcinoma Nagasue, Naofumi Yukaya, Hirofumi Kohno, Hitoshi Chang, Yu-Chung Nakamura, Teruhisa HPB Surg Research Article Major hepatic resection was carried out on 23 adult patients with hepatocellular carcinoma (HCC) and underlying cirrhosis of the liver (macronodular in six cases, micronodular in 11, and mixed type cirrhosis in six). Pre-operative liver functional state was Child's class A in 19, class B in three, and class C in one. The operations performed were extended right lobectomy in four patients, right lobectomy in 10, left lobectomy in one, and left lateral segmentectomy in eight. Fifteen postoperative complications were found in 10 patients, five of whom had duplicated complications and finally died of liver failure 15–65 days after operation. In three of those five patients, other complications (hemorrhagic shock in two and portal thrombosis in one) had preceded liver failure. Eighteen patients tolerated the resection and were discharged from hospital. However, among 13 noncirrhotic patients with HCC who had undergone major hepatic resection during the same period of time, only two had postoperative complications and all patients were discharged from hospital. The 1-, 2- and 3-year survival rates in the 23 cirrhotics were 60.9%, 37.5% and 24.9% respectively, whereas the 1–5-year survival rates were all 61.5% in the 13 noncirrhotics. Thus, major hepatic resection may be indicated in selected patients with HCC and associated cirrhosis, but meticulous managements during and after operation are mandatory to prevent fatal postoperative liver failure. Hindawi Publishing Corporation 1988 /pmc/articles/PMC2423506/ /pubmed/2856432 http://dx.doi.org/10.1155/1988/93437 Text en Copyright © 1988 Hindawi Publishing Corporation. http://creativecommons.org/licenses/by/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Nagasue, Naofumi
Yukaya, Hirofumi
Kohno, Hitoshi
Chang, Yu-Chung
Nakamura, Teruhisa
Morbidity and Mortality After Major Hepatic Resection in Cirrhotic Patients With Hepatocellular Carcinoma
title Morbidity and Mortality After Major Hepatic Resection in Cirrhotic Patients With Hepatocellular Carcinoma
title_full Morbidity and Mortality After Major Hepatic Resection in Cirrhotic Patients With Hepatocellular Carcinoma
title_fullStr Morbidity and Mortality After Major Hepatic Resection in Cirrhotic Patients With Hepatocellular Carcinoma
title_full_unstemmed Morbidity and Mortality After Major Hepatic Resection in Cirrhotic Patients With Hepatocellular Carcinoma
title_short Morbidity and Mortality After Major Hepatic Resection in Cirrhotic Patients With Hepatocellular Carcinoma
title_sort morbidity and mortality after major hepatic resection in cirrhotic patients with hepatocellular carcinoma
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2423506/
https://www.ncbi.nlm.nih.gov/pubmed/2856432
http://dx.doi.org/10.1155/1988/93437
work_keys_str_mv AT nagasuenaofumi morbidityandmortalityaftermajorhepaticresectionincirrhoticpatientswithhepatocellularcarcinoma
AT yukayahirofumi morbidityandmortalityaftermajorhepaticresectionincirrhoticpatientswithhepatocellularcarcinoma
AT kohnohitoshi morbidityandmortalityaftermajorhepaticresectionincirrhoticpatientswithhepatocellularcarcinoma
AT changyuchung morbidityandmortalityaftermajorhepaticresectionincirrhoticpatientswithhepatocellularcarcinoma
AT nakamurateruhisa morbidityandmortalityaftermajorhepaticresectionincirrhoticpatientswithhepatocellularcarcinoma